Abstract:Objective To study the clinical manifestations and gene mutations of Chinese long QT syndrome (LQTS) patients.MethodsAccording to the criteria by Schwartz 1993, probands of 85 families from 18 provinces were diagnosed as LQTS. Among them the information about 43 patients was provided by the National Registry, and a definite diagnosis for others were confirmed in our center. Six or 12 lead ECG for the probands and their family members was recorded and clinical manifestations for all probands were analyzed. Gene mutations were screened in KCNQ1,KCNH2 and KCNE1 using PCR and sequence analysis. ResultsThe age distribution for the first attack of probands is 17.3±14.2, and 60% of patients had their first attack before the age of 20. The sex distribution (male∶female) is around 1∶3, and the most prominent symptom is syncope (91.8%). The triggers are emotional stress (51.3%), physical stress, exercise or overwork (51.3%), during sleep or rest (26.3%), sudden noise/arousal (19.7%), menses or puerperium(15.8%), others (cold or fever) (15.8%). The QTc for probands is (0.56±0.07)s. The T wave morphology is varied, and QT interval could become temporarily normal. The families with sudden death history make up 31.6% of total 85 families. The families with more than 2 LQTS patients make up 63%. Among 85 probands, 1 case accompanied by deaf-mute, 1 case by WPW, 2 cases by myocarditis, 2 cases by bundle branch block, 1 by temporary atrio-ventricular block and 2 by hypertention. The predictive genotypic results by ECG characteristics are LQT1 (29.4%), LQT2(57.6%), LQT3(3.5%), and unpredictable (9.4%). The pacemaker plus β-blocker are effective for 4 patients and ICD plus β-blocker are effective for 1 patient. Left cardiac sympathetic denervation (LCSD) was performed on 15 patients. The therapy with β-blockers was conducted on most of other patients. Seven KCNQ1, 5 KCNH2 and 1 KCNE1 mutations have been identified in Chinese LQTS patients. Coexpression of HERG-R863X with wild-type HERG showed reduced current densities through no trafficing to the cell surface. KCNQ1-L191P and KCNE1-G52R have a dominant negative effect on I Ks, which reduces the I Ks current amplitude. ConclusionThe general clinical manifestations for Chinese LQTS patients are consistent with that reported by investigators from other countries. The predictive genotype results by ECG characteristics suggested that the major genotype for Chinese LQTS patients might be LQT2.β-blockers are the first-line therapy for LQTS patients. LCSD, pacemaker and ICD implantation are the choices for β-blocker resistant patients. Genetic and electrophysiological tests have shown promising results, suggesting that Chinese LQTS patients may have their own specific mutation sites and pathophysiological mechanisms.

Genotype-based clinical manifestation and treatment of Chinese long QT syndrome patients with KCNQ1 mutations - R380S and W305L.

Identification of a KCNE2 Gain-of-Function Mutation in Patients with Familial Atrial Fibrillation

[Novel Mutations of Potassium Channel KCNQ1 S145L and KCNH2 Y475C Genes in Chinese Pedigrees of Long QT Syndrome].

Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.

Clinical Characters and Mutation Analysis of Potassium Channel Genes KCNH2 in 77 Pedigrees of Chinese with Long QT Syndrome

KCNQ1 and KCNH2 Mutations Associated with Long QT Syndrome in a Chinese Population.

Clinical Characteristics of 85 Probands with Long QT Syndrome and an Update of Genetic Study in China

Three Novel Mutations of Potassium Channel HERG and SCN5A in Chinese Families of Congenital Long QT Syndromes

Mutation Analysis of Potassium Channel Genes KCNQ1 and KCNH2 in Patients with Long QT Syndrome

Identification of A Kir3.4 Mutation in Congenital Long Qt Syndrome

Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations

Clinical Aspects of Type-1 Long-Qt Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene.

A Novel Splice Mutation of HERG in a Chinese Family with Long QT Syndrome.

Protective effect of <it>KCNH2 </it>single nucleotide polymorphism K897T in LQTS families and identification of novel <it>KCNQ1 </it>and <it>KCNH2 </it>mutations

Novel Compound Heterozygous Mutations in the KCNQ1 Gene Associated with Autosomal Recessive Long QT Syndrome (jervell and Lange‐Nielsen Syndrome)

Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome.

Association of Ion Channel Genes KCNQ1 and KCNH2 with Congenital Long-QT Syndrome

Mutations In Cytoplasmic Loops Of The Kcnq1 Channel And The Risk Of Life-Threatening Events Implications For Mutation-Specific Response To Beta-Blocker Therapy In Type 1 Long-Qt Syndrome

Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome

Identification of a Novel KCNQ1 Mutation Associated with Both Jervell and Lange-Nielsen and Romano-Ward Forms of Long QT Syndrome in a Chinese Family

Characterization Of A Kcnq1/Kvlqt1 Polymorphism In Asian Families With Lqt2: Implications For Genetic Testing